Skip to main content

Paired Ends: Kevin Shianna, Deanna Church, Leif Andersson, Jorge Dubcovsky

Premium

Kevin Shianna has left the New York Genome Center, where he was most recently deputy scientific director of sequencing operations.

His role has been taken over by Soren Germer and Dayna Oschwald, who both joined the NYGC in early 2012 as sequencing program managers.

Germer was previously a senior principal scientist at Roche Pharmaceuticals, where he led a genetics and next-gen sequencig lab. He holds a PhD from the University of California, Berkeley.

Oschwald came to the NYGC from Washington University School of Medicine, where she was the core manager of the Genome Technology Access Center.

Shianna joined the NYGC in mid-2012 and oversaw the creation of its pilot sequencing laboratory as well as its move to the NYGC's permanent location last year. It is not immediately clear where Shianna has taken up a new position.


Deanna Church has become senior director of genomics and content at Personalis. She joined Personalis from the National Institutes of Health's National Center for Biotechnology Information, where she was a staff scientist for 12 years. She holds a PhD from the University of California, Irvine and a BA from the University of Virginia.


Leif Andersson and Jorge Dubcovsky have received the 2014 Wolf Prize in Agriculture. The Wolf Foundation, an Israeli nonprofit, awards prizes to scientists and artists in the subjects of agriculture, chemistry, mathematics, medicine, physics, and arts each year. The prize consists of a certificate and $100,000 cash award.

Andersson, a professor at Uppsala University in Sweden, was awarded the prize for his work in genomic and marker assisted selection as a means to identify superior breeding stock.

Dubcovsky is a plant geneticist focused on wheat genomics at the University of California, Davis.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.